Blog

Psychedelic News Roundup: August 16th, 2024

Aug 16 • 8 min read

A lot has happened the past week. Let us summarize some of the events surrounding psychedelic drug development companies and the industry as a whole. Lykos Therapeutics Cuts 75% of Staff Lykos Therapeutics announced a reorganization plan following the FDA’s rejection of its application for an MDMA-based drug intended to treat PTSD. Despite the setback,…

Who is the Ketamine Queen?

Aug 16 • 3 min read

Jasveen Sangha, a name that has recently made headlines, is now facing serious legal consequences following the tragic death of actor Matthew Perry. Known in some circles as the “Ketamine Queen,” Sangha has been indicted for her alleged role in Perry’s overdose, a development that has shocked both fans and those aware of her activities…

After Last Week’s FDA Decision, Everyone’s Talking About What’s Next

Aug 16 • 5 min read

After last week’s rejection of MDMA, everyone has been conjecturing about the future of psychedelics as medicine. Questions surrounding all the delays and need for more capital have taken hold of mainstream media. Throughout all of this, one of the most interesting conversations we’ve heard recently is Vivek Ramaswamy’s interview with Balaji Srinivasan. While Psychedelic…

Hempacco Co., Inc. Announces Board and Committee Appointments

Aug 16 • 3 min read

On August 9, 2024, the Board of Directors of Hempacco Co., Inc. appointed Paul Glavine and Harrison Newlands as members of the Board of the Company to fill two vacancies on the Board. Mr. Glavine and Mr. Newlands are both considered ?independent? directors under relevant SEC and Nasdaq rules, and they will each serve with…

Optimi Health Completes Inaugural Export of MDMA Capsules to Australia for PTSD Treatment

Aug 16 • 5 min read

Vancouver, British Columbia–(Newsfile Corp. – August 16, 2024) – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company“), a GMP-approved, Health Canada-licensed psychedelics pharmaceutical manufacturer specializing in botanical psilocybin and MDMA, is pleased to announce it has completed the inaugural export of it’s GMP-validated MDMA capsules to Australia for the treatment…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543